[{"Assets_0_Q2_USD":601395000.0,"CommonStockSharesConverted_0_Q2_shares":13725381.0,"CommonStockSharesOutstanding_0_Q2_shares":13725381.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":262333000.0,"NetIncomeLossConverted_1_Q2_USD":-16369000.0,"NetIncomeLossConverted_2_Q2_USD":-35009000.0,"StockholdersEquity_0_Q2_USD":-284374000.0,"EarningsPerShareBasic_1_Q2_USD":-1.23,"EarningsPerShareBasic_2_Q2_USD":-2.68,"RevenuesConverted_1_Q2_USD":22138000.0,"RevenuesConverted_2_Q2_USD":34804000.0,"Ticker":"ADPT","CIK":"1478320","name":"ADAPTIVE BIOTECHNOLOGIES CORP","OfficialName":"Adaptive Biotechnologies Corporation Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1463975665.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20190813"}]